Virtual Medicinal Product (VMP) - Irinotecan 360mg/240ml infusion bags
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Irinotecan 360mg/240ml infusion bags | Start Date 23-02-2021 | End Date |
| Previous Name | Previous Name Irinotecan 360mg/240ml solution for infusion bags | Start Date 21-12-2020 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 240.0
- UDFS UOM
- ml
- Unit Dose UOM
- bag
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01CE02
| Code | Start Date | End Date |
|---|---|---|
| 39296011000001100 | 21-12-2020 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Irinotecan hydrochloride trihydrate | Based on Ingredient Substance | 1.5 mg | 1 ml |
Name
Irinotecan hydrochloride trihydrate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.5
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMIrinotecan
-
VMP(Current) Irinotecan 360mg/240ml infusion bags
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 bag |